Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?

To: VIPER85730 who wrote (8684)	12/19/1998 8:33:00 AM
From: George Eby	Read Replies (2) \| Respond to of 8960

I got pulled away from what I was doing, and I seemed for the moment to be the person with the least to say! To update you on the zinc lozenge front (various licensees), I can not understand why The Q stock is so low in price. I know of no factors that should keep the price so low. Perhaps, as others has observed, there were fewer colds this year (1998), but I have no data that would support that idea. Perhaps new clinical studies would generate more public awareness. The recent NIH Zinc Workshop did nothing to help or hurt sales. The NIH presenters excluded the four most knowledgeable zinc experts in the world and was generally a second rate production.